Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M102089200 on May 30, 2001

J. Biol. Chem., Vol. 276, Issue 31, 29134-29140, August 3, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/31/29134    most recent
M102089200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueno, M.
Right arrow Articles by Sugahara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueno, M.
Right arrow Articles by Sugahara, K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structural Characterization of Heparan Sulfate and Chondroitin Sulfate of Syndecan-1 Purified from Normal Murine Mammary Gland Epithelial Cells

COMMON PHOSPHORYLATION OF XYLOSE AND DIFFERENTIAL SULFATION OF GALACTOSE IN THE PROTEIN LINKAGE REGION TETRASACCHARIDE SEQUENCE*

Momoyo UenoDagger , Shuhei YamadaDagger , Masahiro Zako§, Merton Bernfield§, and Kazuyuki SugaharaDagger

From the Dagger  Department of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe 658-8558, Japan and the § Departments of Pediatrics and Cell Biology, Harvard Medical School, Children's Hospital, Boston, Massachusetts 02115

Received for publication, March 8, 2001, and in revised form, May 24, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Syndecan-1, present on the surfaces of normal murine mammary gland epithelial cells, is a transmembrane hybrid proteoglycan, which bears glycosaminoglycan (GAG) side chains of heparan sulfate (HS) and chondroitin sulfate (CS). Purified syndecan-1 ectodomains were analyzed for disaccharide composition and the GAG-protein linkage region after digestion with bacterial lyases. The HS chains contained predominantly a nonsulfated unit with smaller proportions of two monosulfated, two disulfated, and a trisulfated unit, whereas CS chains were demonstrated for the first time to bear GlcUA-GalNAc(4-O-sulfate) as a major component as well as GlcUA-GalNAc, GlcUA-GalNAc(6-O-sulfate), and an E disaccharide unit GlcUA-GalNAc(4,6-O-disulfate) as minor yet appreciable components. Two kinds of linkage region tetrasaccharides, GlcUA-Gal-Gal-Xyl and GlcUA-Gal-Gal-Xyl(2-O-phosphate), were found for the HS chains in a molar ratio of 55:45. In marked contrast, an additional sulfated tetrasaccharide, GlcUA-Gal(4-O-sulfate)-Gal-Xyl, was demonstrated only for the CS chains, and the unmodified phosphorylated and sulfated components were present at a molar ratio of 55:26:19. The present study thus provided conclusive evidence for the hypothesis that 4-O-sulfation of Gal is peculiar to CS chains in contrast to the phosphorylation of Xyl, which is common to both HS and CS chains. These modifications may be required for biosynthetic maturation of the linkage region tetrasaccharide sequence, which is a prerequisite for creating the repeating disaccharide region of GAG chains and/or biosynthetic selective chain assembly of CS and HS chains.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Proteoglycans (PGs)1 are macromolecules composed of glycosaminoglycan (GAG) side chains covalently bound to a protein core (1). PGs have been implicated in the regulation and maintenance of cell proliferation, cytodifferentiation, and tissue morphogenesis where the characteristic GAG moieties specifically interact with protein ligands, which include a wide variety of growth and/or differentiation factors, cytokines, and morphogens (2-5). GAGs include chondroitin/dermatan sulfate (CS/DS) and heparan sulfate/heparin (HS/Hep), which are classified as galactosaminoglycans and glucosaminoglycans, respectively. Major components of these linear GAGs, except for branched keratan sulfate, consist of hexosamine (GalNAc, GlcNAc, or 2-N-sulfated GlcN) and hexuronic acid (GlcUA or IdoUA) units, which are arranged in alternating sequences to form the so-called repeating disaccharide region. These repeating units contain a number of sulfate substituents at various positions (1), which create a massive degree of structural and functional diversity. Both types of GAGs are covalently bound to Ser residues in the core proteins through the common GAG-protein linkage structure, GlcUAbeta 1-3Galbeta 1-3Galbeta 1-4Xylbeta 1-O-Ser (6). This conformity contrasts sharply with the structural heterogeneity of the repeating disaccharide region. Hence, the question arises how these different GAGs can be synthesized on the same structure, especially because the chain elongation proceeds in a stepwise fashion and is governed largely by the substrate specificity of the glycosyltransferases involved (7, 8).

We have carried out a series of structural studies of the GAG-protein linkage region based on the working hypothesis that possible structural differences in the linkage region may exist among the various GAG chains and determine the type and/or character of the GAG species to be synthesized (7). These and other studies have led to the identification of novel modified structures, such as GlcUAbeta /IdoUAalpha 1-3Gal(4-O-sulfate)beta 1-3Gal(±6-O-sulfate)beta 1-4Xyl, GlcUAbeta 1-3Gal(± 6-O-sulfate)beta 1-3Gal(±6-O-sulfate)beta 1-4Xyl, and GlcUAbeta 1-3Galbeta 1-3Galbeta 1-4Xyl(2-O-phosphate), for CS/DS chains (7, 9-19). Interestingly, sulfated Gal residues have been demonstrated so far in the linkage region of CS and DS but not in HS or Hep, whereas a 2-O-phosphorylated Xyl residue has been found in both HS/Hep and CS, indicating that the sulfate groups on the Gal residues may be signals for biosynthetic selective assembly of CS/DS (7, 8), and that the modifying sulfate and/or phosphate groups may be the key elements that control the glycosyltransferases involved in the formation of the linkage region, thereby regulating the maturation of "part-time PGs" (20). Despite the intriguing contrast in the Gal sulfation and the attractive possibilities, it remains to be examined whether such differential and common modifications indeed reflect the indispensable features of the constitutive biosynthetic machinery or cell-, tissue-, or species-dependent modifications.

To clarify these issues and also examine whether the Gal sulfation is indeed characteristic of only CS/DS chains and not of HS chains, we analyzed in this study syndecan-1, a transmembrane hybrid PG that contains both HS and CS side chains on the same core protein. Syndecan-1 is involved in a variety of important biological phenomena through interactions, at least, of its HS chains with specific protein ligands, such as fibroblast growth factors, various morphogens, and microbial pathogens (4, 21-23). The functions of the CS chains have not been investigated as thoroughly. In view of the hybrid structural feature, the biosynthetic sorting of HS and CS is of critical importance to express HS- or CS-specific biological activities. Recently, we developed a sensitive analytical method for GAG-protein linkage region oligosaccharides by treatment with LiOH and fluorescent labeling (24). This method was applied to the analysis of the GAG-protein linkage region oligosaccharides derived from the extracellular domains (ectodomains) of purified syndecan-1 prepared from the conditioned medium of cultured NMuMG (normal murine mammary gland) epithelial cells. Differential sulfation of one of the galactose residues and common phosphorylation of the xylose residue were demonstrated.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Heparitin-sulfate lyase (EC 4.2.2.8) available as heparitinase, heparinase (EC 4.2.2.7), chondroitin ABC lyase (EC 4.2.2.4), chondroitin AC lyase from Arthrobacter aurescens (EC 4.2.2.5), chondro-4-sulfatase (EC 3.1.6.9), chondro-6-sulfatase (EC 3.1.6.10), and unsaturated disaccharides derived from CS were obtained from Seikagaku Corp. (Tokyo, Japan). Calf intestine alkaline phosphatase (EC 3.1.3.1) of special quality for molecular biology was from Roche Molecular Biochemicals (Tokyo, Japan), Ampullaria (freshwater apple shell) hepatopancreas beta -glucuronidase (EC 3.2.1.31) purified to homogeneity (25) was provided by Tokyo Zouki Chemical Co. (Tokyo, Japan). 2-Aminobenzamide (2AB) was purchased from Nacalai Tesque (Kyoto, Japan). Unsaturated disaccharides derived from Hep and HS were prepared as described previously (26). The following 2AB-derivatives of the authentic unsaturated tetrasaccharides of the GAG-protein linkage region were prepared as described previously (24) from various CS preparations: Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl-2AB, Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl(2-O-phosphate)-2AB, Delta HexUAalpha 1-3Gal(4-O-sulfate)beta 1-3Galbeta 1-4Xyl-2AB, and Delta Hex-UAalpha 1-3Galbeta 1-3Gal(6-O-sulfate)beta 1-4Xyl-2AB.

Preparation of Cell Surface Syndecan-1 Ectodomains-- Soluble proteoglycans are shed from the surfaces of subconfluent NMuMG cell cultures. NMuMG cells at relatively early passages (10-14) were cultured to 50% confluence (27), and the conditioned media were used to prepare purified syndecan-1 ectodomains as described previously (28). After anion exchange chromatography, the samples were subjected to CsCl density gradient centrifugation, and the fractions at density higher than 1.35 g/ml were collected for purification of syndecan-1 ectodomains using an mAb 281-2 affinity column. For preparation of the immunoaffinity column, the rat monoclonal antibody 281-2 directed against the mouse syndecan-1 ectodomain core protein (29) was conjugated to CNBr-activated Sepharose 4B and used as described previously (28). Protein concentration was determined using the BCA protein assay kit (Pierce) with bovine serum albumin as a standard (30).

The amount of syndecan-1 ectodomain core protein was routinely established in an immunochemical assay using monoclonal antibody 281-2 (31). Carbazole assay using heparin as a standard was used to measure the amount of GAG. These assays were standardized by comparison with the average values obtained by automated amino acid and amino sugar analyses (32). Purity was assessed by comparing silver-stained gels from SDS-polyacrylamide gel electrophoresis, which bore various amounts of the immunoaffinity purified GAG-free ectodomain core protein. No contaminating proteins were noted at a level of detection corresponding to one-tenth the amount of ectodomain core protein. This lack of detectable contaminant(s) indicates that at least 90% of the preparation was the ectodomain core protein.

Preparation of the 2AB-derivatives of the GAG Chains from Syndecan-1 Ectodomains-- The purified syndecan-1 ectodomains (3.7 µg as the core protein) were treated with 0.5 M LiOH at 4 °C for 13 h to liberate O-linked saccharides from the core protein (24, 33). After neutralization with 1.7 M acetic acid, the sample was applied to a column (300 µl) of anion-exchange resin AG 50W-X2 (H+ form, Bio-Rad) equilibrated with H2O. The flow-through fraction containing the liberated O-linked saccharides was neutralized with 1 M NH4HCO3. Derivatization of the saccharides with 2AB and initial purification of the derivatives were carried out by paper chromatography as described previously (34). To further purify the 2AB-derivatives, the samples were subjected to gel filtration on a PD-10 column (Amersham Pharmacia Biotech) using 50 mM pyridine-acetate buffer, pH 5.0, as an effluent (24). Eluates were monitored by fluorescence with excitation and emission wavelengths at 330 and 420 nm, respectively. The flow-through fraction containing 2AB-derivatized GAG chains, the right shoulder (Fr. A) of the GAG fraction and a broad fluorescent peak (Fr. B) eluted afterward, both of which might contain O-linked oligosaccharides, were separately pooled as shown in Fig. 1 and lyophilized. The 2AB-derivatized GAG chains were analyzed as described below. Frs. A and B were analyzed by anion-exchange HPLC on an amine-bound silica PA-03 column or by gel filtration HPLC on a column (7.6 × 500 mm) of Asahipac GS320 as described previously (12, 34) before and after beta -glucuronidase digestion.


View larger version (18K):
[in this window]
[in a new window]
  		Fig. 1.   Analysis of the 2AB-derivatized saccharide fraction by gel filtration chromatography on a PD-10 column. The O-linked saccharides of the purified syndecan-1 ectodomains were liberated from the core protein by treatment with LiOH and derivatized with 2AB as described under "Experimental Procedures." The 2AB-derivatives were separated from the reagents by paper chromatography. To further purify the 2AB-derivatives, the samples were subjected to gel filtration on a PD-10 column using 50 mM pyridine-acetate buffer, pH 5.0. Eluates were monitored by fluorescence with excitation and emission wavelengths at 330 and 420 nm, respectively. The flow-through fraction containing 2AB-derivatized GAG chains, the right shoulder (Fr. A) of the GAG fraction, and a broad fluorescent peak (Fr. B) eluted afterward, both of which might contain O-linked oligosaccharides, were separately pooled, lyophilized, and analyzed.

Enzymatic Treatments and HPLC Analysis-- Enzymatic treatments for disaccharide composition analysis of GAG chains were carried out as follows. The purified syndecan-1 ectodomains (150 or 38 ng as core protein) were treated with chondroitin ABC lyase (5 mIU) in a total volume of 20 µl of 0.05 M Tris-HCl buffer, pH 8.0, containing 0.06 M sodium acetate at 37 °C for 10 min (35) or with a mixture of heparinase and heparitin-sulfate lyase (0.5 mIU each) in a total volume of 20 µl of acetate-NaOH buffer, pH 7.0, containing 10 mM Ca(OAc)2 at 37 °C for 1 h (36), respectively. The digests were treated with a fluorophore 2AB to label reducing termini of GAG disaccharides and analyzed by HPLC on an amine-bound silica column as described previously (34).

Enzymatic treatment of 2AB-derivatized GAG chains (~20 pmol) with chondroitin ABC lyase was carried out as reported (34) using 7.5 mIU of the enzyme in a total volume of 25 µl for 30 min. The chondroitin ABC lyase digest was further treated with 7.5 mIU of chondroitin AC lyase in a total volume of 50 µl of 0.05 M sodium acetate buffer, pH 6.0, at 37 °C for 30 min. Chondro-4-sulfatase treatment of the chondroitin ABC lyase digests was carried out using 40 mIU of the enzyme in a total volume of 100 µl of 34 mM Tris-HCl buffer, pH 7.5, containing 34 mM sodium acetate and 100 µg/ml bovine serum albumin at 37 °C for 30 min (37). Enzymatic treatment of 2AB-derivatized GAG chains (~20 pmol) with a mixture of heparinase and heparitin-sulfate lyase (3 mIU each) was carried out in a total volume of 50 µl for 3 h as reported previously (36). Alkaline phosphatase treatment was carried out using 4 IU of the enzyme in a total volume of 100 µl of 0.08 M glycine/NaOH buffer, pH 9.9, containing 0.5 mM MgCl2 at 37 °C for 30 min (12). The enzymatic reactions were terminated by heating at 100 °C for 1 min, and each enzyme digest was analyzed by anion-exchange HPLC on an amine-bound silica PA-03 column or by gel filtration HPLC on a column of Asahipac GS320 as described previously (12, 34). Eluates were monitored by fluorescence intensity with excitation and emission wavelengths of 330 and 420 nm or by absorbance at 232 nm.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Disaccharide Composition Analysis of HS and CS Chains-- The purified syndecan-1 ectodomains were digested exhaustively with chondroitin ABC lyase or a mixture of heparinase and heparitin-sulfate lyase, and the resulting disaccharides were labeled with 2AB and analyzed by HPLC on an amine-bound silica column. Each disaccharide peak was identified by comparison of the elution positions with those of the standard 2AB-disaccharides (Fig. 2). The major disaccharide units in HS chains were Delta DiHS-0S ([Delta HexUA-GlcNAc]) and Delta DiHS-NS ([Delta HexUA-GlcN(2-N-sulfate)]), which accounted for 58 and 23%, respectively (Fig. 2A). The small yet appreciable amounts of other disaccharide units, Delta DiHS-6S ([Delta HexUA-GlcNAc(6-O-sulfate)]), Delta DiHS-diS1 ([Delta HexUA-GlcN(2-N-, 6-O-disulfate)]), Delta DiHS-diS2 ([Delta HexUA(2-O-sulfate)-GlcN(2-N-sulfate)]), and Delta DiHS-triS ([Delta HexUA(2-O-sulfate)-GlcN(2-N-, 6-O-disulfate)]), were also found. These findings are in agreement with previous data (28). Nearly 36% of the disaccharides were N- sulfated, and 11% each of the disaccharides contained hexuronate 2-O-sulfate or glucosamine 6-O-sulfate residue. The 2-N-sulfate content was relatively high compared with that of 2-O-sulfate or 6-O-sulfate. The yield of each disaccharide was calculated based on the fluorescence intensity (34) and the composition of the syndecan-1 HS chains. A summary is given in Fig. 3A.


View larger version (16K):
[in this window]
[in a new window]
  		Fig. 2.   Disaccharide composition analysis of HS and CS chains of syndecan-1. Syndecan-1 ectodomains (38 or 150 ng as core protein) were digested with a mixture of heparinase and heparitin-sulfate lyase or chondroitin ABC lyase for disaccharide composition analysis of HS (A) or CS (B), respectively. The digests were labeled with a fluorophore 2AB and analyzed by HPLC on an amine-bound silica column as described under "Experimental Procedures" . The elution positions of authentic 2AB-disaccharide standards derived from HS and CS are indicated by numbered arrows in A and B, respectively. 1, Delta DiHS-0S; 2, Delta DiHS-6S; 3, Delta DiHS-NS; 4, Delta DiHS-diS1; 5, Delta DiHS-diS2; 6, Delta DiHS-triS; 7, Delta Di-0S; 8, Delta Di-6S; 9, Delta Di-4S; 10, Delta Di-diSD; 11, Delta Di-diSE; 12, Delta Di-triS.


View larger version (23K):
[in this window]
[in a new window]
  		Fig. 3.   Diagrammatic presentation of the structural findings of HS and CS chains of syndecan-1. The diagrams of HS (A) and CS (B) chains were illustrated based on the findings obtained from the analyses of the disaccharide composition (see Fig. 2) and the GAG-protein linkage region (see Figs. 4 and 5). 2P, 2-O-phosphate in the linkage region; 4S, 4-O-sulfate in the linkage region.

Chondroitin ABC lyase digestion of the purified syndecan-1 ectodomains yielded Delta Di-0S ([Delta HexUA-GalNAc]), Delta Di-4S ([Delta HexUA-GalNAc(4-O-sulfate)]), Delta Di-6S ([Delta HexUA-GalNAc(6-O-sulfate)]), and Delta Di-diSE ([Delta HexUA-GalNAc(4,6-O-disulfate)]) at a molar ratio of 29:59:5:7 (Fig. 2B). Chondroitin AC lyase digestion gave very similar results indicating that most, if not all, of the uronic acid residues were GlcUA. The identity of the latter two minor peaks was confirmed based on the sensitivity to chondro-6-sulfatase. Upon digestion, these peaks were shifted to the positions of Delta Di-0S and Delta Di-4S, respectively (data not shown). The yield of each disaccharide was calculated based on the fluorescence intensity and the composition of the CS chains. The data are summarized in Fig. 3B. The disaccharide compositions obtained using 2AB-derivatization were comparable with those based on the UV absorbance of the underivatized unsaturated disaccharides (data not shown).

Structural Analysis of the CS-protein Linkage Region-- The purified syndecan-1 ectodomains were treated with LiOH to liberate O-glycosylated glycan chains including GAGs from the core protein (24, 33). The liberated saccharides were labeled with a fluorophore 2AB. A mixture of 2AB-labeled GAG chains was recovered in the flow-through fraction on gel filtration using a PD-10 column (Fig. 1). The 2AB-labeled tetrasaccharides derived from the CS-protein linkage region were obtained by digesting the repeating disaccharide region using chondroitin ABC and AC lyases. Depolymerization of CS by chondroitin ABC lyase results in various sulfated disaccharide units and core hexasaccharides that are derived from the linkage region (7). Chondroitin AC lyase degrades a linkage region hexasaccharide into a disaccharide unit and a core tetrasaccharide (11). The resulting 2AB-derivatized linkage region tetrasaccharides were analyzed by HPLC on an amine-bound silica column (Fig. 4). As shown in Fig. 4B, three predominant peaks were observed at the elution positions of the authentic 2AB-tetrasaccharides, Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl-2AB, Delta HexUAalpha 1-3Gal(4-O-sulfate)beta 1-3Galbeta 1-4Xyl-2AB, and Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl(2-O-phosphate)-2AB, in a molar ratio of 55:19:26. When this sample was co-chromatographed with the standard linkage tetrasaccharides, these peaks were co-eluted with the corresponding standards (data not shown), confirming the identity of these peaks.


View larger version (17K):
[in this window]
[in a new window]
  		Fig. 4.   HPLC analysis of the CS-protein linkage region tetrasaccharides prepared from syndecan-1. The 2AB-labeled tetrasaccharides derived from the CS-protein linkage region were prepared by successive digestions of 2AB-derivatized GAG chains with chondroitin ABC and AC lyases and analyzed by HPLC on an amine-bound silica column before (B) or after subsequent treatments with either chondro-4-sulfatase (C) or alkaline phosphatase (D). The elution positions of authentic 2AB-tetrasaccharide standards (6.5 pmol each) are indicated by numbered arrows in A. 1, Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl-2AB; 2, Delta HexUAalpha 1-3Galbeta 1-3Gal(6-O-sulfate)beta 1-4Xyl-2AB; 3, Delta HexUAalpha 1-3Gal(4-O-sulfate)beta 1-3Galbeta 1-4Xyl-2AB; 4, Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl(2-O-phosphate)-2AB. Peaks marked by asterisks were derived from the incubation buffer or the enzyme preparation and are artifacts.

Upon subsequent chondro-4-sulfatase digestion, the peak eluted at the position of Delta HexUAalpha 1-3Gal(4-O-sulfate)beta 1-3Galbeta 1-4Xyl-2A was shifted to the position of the authentic nonsulfated 2AB-tetrasaccharide (Fig. 4C). These data indicated that the compound in the peak contained a 4-O-sulfate group most probably located on the C4 position of the Gal(II) residue in the linkage tetrasaccharide sequence GlcUAbeta 1- 3Gal(II)beta 1-3Gal(I)beta 1-4Xyl. Although it was not feasible to distinguish between Delta HexUAalpha 1-3Gal(4-O-sulfate)beta 1- 3Galbeta 1-4Xyl and Delta HexUAalpha 1-3Galbeta 1-3Gal(4-O-sulfate)beta 1-4Xyl because of the lack of the latter authentic standard, the latter structure has not been reported and is therefore unlikely. Upon subsequent alkaline phosphatase digestion, the peak that eluted at the position of Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl(2-O-phosphate)-2AB was shifted by 16 min to the position of the nonsulfated tetrasaccharide as an unusually broad peak (Fig. 4D). An authentic nonsulfated 2AB-tetrasaccharide, Delta HexUAalpha 1- 3Galbeta 1-3Galbeta 1-4Xyl-2AB, also showed a similar broad peak when chromatographed with the phosphatase preparation (data not shown), indicating that the broadness of the peak was attributed to the phosphatase preparation for yet unknown reasons. These findings from the alkaline phosphatase digestion indicated that the compound in the peak, which eluted after ~27 min, contained a phosphate group most probably located on the C2 position of the Xyl residue in the linkage region tetrasaccharide structure. Although C3 phosphorylation of the Xyl residue is possible, such a structure has not been reported, and a phosphate group has been found only at the C2 position (9, 10, 12, 13), indicating that the phosphate group is most probably located at the C2 position of the Xyl residue.

Structural Analysis of the HS-protein Linkage Region-- The 2AB-labeled tetrasaccharides derived from the HS-protein linkage region were also analyzed by HPLC after digesting the repeating disaccharide region using a mixture of bacterial heparinase and heparitin-sulfate lyase. Because heparitin-sulfate lyase cleaves the innermost glucosaminidic bond of HS (38, 39), the enzyme digestion results in various sulfated disaccharide units and linkage region core tetrasaccharides. As shown in Fig. 5A, two major peaks were observed at the elution positions of the authentic 2AB-tetrasaccharides, Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl-2AB and Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl(2-O-phosphate)-2AB, in a molar ratio of 55:45. When this sample was co-chromatographed with the standard linkage tetrasaccharides, the two peaks were co-eluted with the corresponding standards (data not shown). Upon subsequent alkaline phosphatase digestion, the peak that eluted at the position of Delta HexUA-Gal-Gal-Xyl(2-O-phosphate)-2AB was shifted to the elution position of the nonsulfated tetrasaccharide (Fig. 5B), indicating that the compound in the peak contained a phosphate group most probably located on the C2 position of the Xyl residue in the linkage region tetrasaccharide sequence as discussed above for the CS linkage region. The broadness of the peak of the dephosphorylated tetrasaccharide-2AB in the alkaline phosphatase digest was observed as in the case of the HS-derived sample.


View larger version (17K):
[in this window]
[in a new window]
  		Fig. 5.   HPLC analysis of the HS-protein linkage region tetrasaccharides prepared from syndecan-1. The 2AB-labeled tetrasaccharides derived from the HS-protein linkage region were prepared by digestion of 2AB-derivatized GAG chains with a mixture of heparinase and heparitin-sulfate lyase and analyzed by HPLC on an amine-bound silica column before (A) or after (B) digestion with alkaline phosphatase. The elution positions of the authentic 2AB-tetrasaccharides are indicated in A (see the legend to Fig. 4). The peak marked by an asterisk in B was derived from the incubation buffer or the enzyme preparation and is an artifact.

Unique modifications of the sequence in the vicinity of the linkage region may render the linkage region resistant to chondroitin lyases and/or heparinase/heparitin-sulfate lyase. Therefore, the enzymatic susceptibility of the GAG chains was investigated. The 2AB-labeled GAG preparation was analyzed by gel filtration HPLC (see under "Experimental Procedures") before and after the enzymatic digestion to clarify the susceptibility of the linkage region structures to the enzymes. When the enzymatic digest that was prepared by treatment with a mixture of heparinase and heparitin-sulfate lyase and subsequently with chondroitin ABC and AC lyases was analyzed, two major peaks and a minor peak were detected at the elution positions of the authentic linkage 2AB-tetrasaccharides, Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl-2AB, Delta HexUAalpha 1-3Galbeta 1-3Galbeta 1-4Xyl(2-O-phosphate)-2AB, and Delta HexUAalpha 1-3Gal(4-O-sulfate)beta 1-3Galbeta 1-4Xyl-2AB, respectively (data not shown). The identity of the two major peaks was confirmed by anion-exchange HPLC of the isolated fractions on an amine-bound silica PA-03 column (data not shown). Thus, the peaks detected on the gel filtration HPLC analysis must be derived from the GAG-protein linkage region of syndecan-1. No other peaks were detected on the gel filtration HPLC analysis of the enzymatic digest, indicating that the 2AB-tetrasaccharides obtained in this study accounted for all the GAG chains of syndecan-1. Taken together, these findings indicate that the GAGs from syndecan-1 are composed of the structures summarized in Fig. 3.

Syndecan-1 ectodomains may contain immature truncated small O-linked oligosaccharides, which are structurally related to the GAG-protein linkage region. Therefore, we examined the putative oligosaccharide fractions (Frs. A and B) observed after the 2AB-GAG fraction (Fig. 1) when the 2AB-derivatized saccharide fraction was subjected to gel filtration chromatography on a PD-10 column (see under "Experimental Procedures"). Although both Frs. A and B gave a few major and several very minor fluorescent peaks when analyzed by anion-exchange or gel filtration HPLC (see under "Experimental Procedures"), none of the major peaks was observed at the elution position of the authentic 2AB-tetrasaccharide, GlcUAbeta 1-3Galbeta 1- 3Galbeta 1-4Xyl-2AB, prepared from alpha -thrombomodulin (57), or sensitive to the action of beta -glucuronidase. These peaks were also resistant to heparitin-sulfate lyase, indicating the absence of the truncated pentasaccharide, GlcNAcalpha 1-4GlcUAbeta 1- 3Galbeta 1-3Galbeta 1-4Xyl-2AB. These results were consistent with the data obtained by matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis (not shown), which showed no signals corresponding to the 2AB-derivatives of the linkage pentasaccharides or tetrasaccharides. Hence, the syndecan-1 ectodomains did not contain appreciable amounts of immature linkage region tetrasaccharides or pentasaccharides, although the possibility cannot be excluded because of the limit of the sensitivity of the method that Frs. A or B contained the linkage region-associated disaccharide or trisaccharide stubs.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, we determined the structure of the GAG-protein linkage region and the disaccharide composition and average size of the CS and HS chains of purified syndecan-1 ectodomains from the surfaces of NMuMG cells. The phosphorylation of the Xyl residue in the linkage region was shown for both HS and CS chains, whereas the 4-O-sulfation of the Gal residue was demonstrated only for the CS but not for HS chains, which was in good agreement with our previous findings (8). In the CS linkage region, the Gal sulfation and Xyl phosphorylation were not found on the same chain, which is also consistent with the previous proposal that they are mutually exclusive (13, 14). These modifications show a rather wide distribution in various tissues of many different vertebrate species. 2-O-Phosphorylation of Xyl has been found for CS from shark cartilage (13), rat (40) and mouse (12) tumors, and for CS/DS from rat fibroblast cell line (41). It was also found for HS/Hep from bovine lung (10, 42). 4-O-Sulfation of Gal has been reported for CS from rat chondrosarcoma (7), whale cartilage (11), bovine cartilage (18, 43), human trypsin inhibitors (16, 17); it was also reported for DS from bovine aorta (15). In addition, Gal 6-O-sulfation has also been revealed for CS from shark cartilage (13, 14) and bovine articular cartilage (19).

The GAG-protein linkage region is formed by the sequential stepwise addition of each monosaccharide residue from the corresponding sugar nucleotide to a specific serine residue in a core protein (1, 8). It is conceivable that the biosynthesis of the linkage region tetrasaccharide is strictly regulated, because it is located at the critical determining point not only for the selective chain assembly of HS/Hep and CS/DS but also for converting proteins into PGs. alpha -GlcNAc transferase I (44-46) and putative beta -GalNAc transferase I (47, 48), which transfer the first GlcNAc and GalNAc residue, respectively, are thought to be the key enzymes that determine the GAG species to be synthesized on the common tetrasaccharide linkage region (8). Hence, an intriguing possibility exists where the Gal 4-O-sulfate structure may be a biosynthetic sorting signal for the selective chain assembly of CS/DS and recognized by putative beta -GalNAc transferase I or chondroitin synthase (8), although the amino acid sequence of the core protein also has a profound influence on the type of GAG chains to be synthesized (49-52). The verification of this hypothesis awaits cloning and expression of the transferase gene.

A number of PG precursor proteins often lack GAG side chains, thus called part-time PGs (8, 20). However, the biosynthetic molecular mechanism by which a given protein containing the GAG attachment consensus amino acid sequence becomes a PG remains obscure. For investigating this issue, it is essential to clarify the substrate specificities and regulatory mechanisms of the glycosyltransferases involved in the synthesis of the linkage region tetrasaccharide sequence. In this respect, the modification of the linkage region by phosphorylation and sulfation may play important roles in the assembly of GAG chains of PG core proteins. The modification of the linkage region of the CS and HS derived from syndecan-1 purified from the same source was only found on some chains and not on others. The modifications were also heterogeneous as seen for the discrete phosphorylated and sulfated linkage region structures. However, a prominent example of the homogeneous linkage region structure has been revealed for inter-alpha -trypsin inhibitor (16) and urinary trypsin inhibitor (17), which bear a single CS chain with a uniform linkage region structure, GlcUAbeta 1-3Gal(4-O-sulfate)beta 1-3Galbeta 1-4Xyl. These findings and the wide distribution of modifications including this structure suggest the possibility that the phosphate and/or sulfate groups are added uniformly to the specific positions in the linkage region and then removed enzymatically during the early stages in the biosynthesis of the linkage region, thus exhibiting dynamic processing features. Notably, a variety of linkage region structures have been reported for CS chains from shark (13, 14), bovine (43), and human (43) cartilage.

Although the exact subcellular compartments for the Xyl phosphorylation and Gal sulfation remain unknown and the responsible kinase and sulfotransferases have not been identified, they may take place in the endoplasmic reticulum or Golgi. Fransson and his co-workers (41, 53, 54) have reported that the phosphorylation of Xyl is a transient phenomenon and is not inhibited by brefeldin A, which interferes with progression from the endoplasmic reticulum to Golgi. They have also found in the early steps of the CS chain biosynthesis of decorin that the degree of phosphorylation increases to ~90% until the linkage region grows into the Gal-Gal-Xyl trisaccharide, and then dephosphorylation takes places extensively accompanied by glucuronidation. This may indicate that the phosphate group on the Xyl residue plays an important role for the transfer reaction of a GlcUA residue to the trisaccharide. In fact, we have observed that the synthetic phosphorylated trisaccharide-serine, Gal-Gal-Xyl(2-O-phosphate)-Ser, served as a better acceptor substrate than the unmodified counterpart for recombinant human GlcUA transferase I.2 The acceptor recognition by a crystallized form of this GlcUA transferase I has recently been demonstrated by x-ray crystallography (55), and it has further been revealed that the crystallized enzyme specifically recognized the 6-O-sulfate group on the Gal(I) residue adjacent to the Xyl residue,2 although it remains to be determined whether the phosphate on the Xyl and/or the 4-O-sulfate group on the Gal(II) residue can also be recognized by the crystallized enzyme. These findings suggest that the phosphorylation of the Xyl residue and sulfation of the Gal residues may be required for efficient elongation and maturation of the linkage region tetrasaccharide as prerequisites for the assembly of GAG chains.

Syndecan-1 core protein contains three potential HS attachment sites near its N terminus and two possible CS attachment sites in the extracellular domain near its transmembrane region (56). HS and CS of the analyzed core protein (3.7 µg) of 33 kDa, which corresponded to 0.11 nmol, yielded 24 and 8 nmol of disaccharides, and 0.23 and 0.17 nmol of linkage oligosaccharides, respectively, indicating that the average sizes of HS and CS chains were ~52 and 23 kDa, respectively. The average size of the HS chains was roughly within the reported range (28), although the average size of the CS chains has not previously been reported. The recoveries of the HS and CS linkage region oligosaccharides were ~70 and 77%, respectively, of the expected values, suggesting that all GAG attachment sites might not be occupied by GAG chains as described previously (56).

We have previously shown that unglycanated alpha -thrombomodulin (a non-PG form) has the linkage tetrasaccharide at the GAG attachment site (57), suggesting that a critical determining step for the biosynthesis of glycanated beta -thrombomodulin (a PG form) appears to be the transfer of the fifth sugar residue, GalNAc, to the linkage region tetrasaccharide. However, such a 2AB-tetrasaccharide with the linkage region-specific sequence was not found in the syndecan-1 preparation used in this study (see under "Results"). Therefore, the addition of GAG chains to the syndecan-1 core protein appears to be regulated by a different mechanism (57, 58) (see under "Discussion"). In view of the possible modifications by sulfation and phosphorylation of the linkage region and their specific recognition by GlcUA transferase I as described above, the linkage region synthesis may be regulated variably during multiple modification and glycosylation steps and may yield an unglycanated part-time PG when inhibited during any one of these steps of the chain elongation during maturation of the linkage region tetrasaccharide sequence, which would provide multiple regulatory points during the conversion of a nonglycanated to glycanated PG. Vigorous examinations are required for detecting possible small biosynthetic intermediate oligosaccharides (41, 53), which may be generated during the maturation process of the linkage region of the syndecan-1 GAG chains.

The CS chains of syndecan-1 were analyzed for the first time, to our knowledge, in terms of the disaccharide composition. The extent of CS chain sulfation was higher than that of the HS chains (the average number of sulfate groups/100 disaccharides was 78 and 58, respectively). The CS chains were modified mainly at the C4 or C6 position of GalNAc residues but also contained a small yet appreciable proportion (7%) of the disulfated E disaccharide unit, Delta HexUA-GalNAc(4,6-O-disulfate) (Fig. 3). This unit has recently attracted attention (for review see Ref. 59), because an oversulfated CS variant, CS-E, that contains E units has neurite outgrowth promoting activities toward embryonic rat hippocampal neurons (60, 61) and high affinity binding activities to Hep-binding neuroregulatory factors, midkine (62, 63) and pleiotrophin (Hep-binding growth-associated molecule) (62, 64), in the same unique gene family. In fact, midkine and pleiotrophin bind to syndecan-1 during early and late embryogenesis, respectively, of the rat central nervous system (65). The CS chains of syndecan-1 may be involved in the regulation of the receptor binding of these Hep-binding protein ligands. It is conceivable that they compete with the HS chains for these factors, or the CS chains localized in the proximity of the cell surface (4, 56) may receive these factors from the HS chains in the distal region from the cell surface and transmit them to the high affinity receptors in the plasma membrane (66). Similar regulatory mechanisms by the CS chains may function for other Hep-binding proteins, such as fibroblast growth factor-2 (67), morphogen-like Wingless and Hedgehog proteins (22), lipoprotein lipase (68), and various collagen types (69), which specifically bind to the HS chains of syndecan-1. Notably, CS-E has been shown to specifically bind to lipoprotein lipase (70) and multiple collagen types as well (71). DS chains that are structurally analogous to CS, released after injury, specifically bind to fibroblast growth factor-2 to promote its cell proliferation activity (72). However, it remains to be clarified what specific functions the CS-E structure of syndecan-1 exhibits in different biological systems.

    FOOTNOTES

* This work was supported in part by the Science Research Promotion Fund from Japan Private School Promotion Foundation, and Grants-in-aid for Encouragement of Young Scientists 11771474 (to S. Y.), Scientific Research 13470493 (to K. S.), and Scientific Research on Priority Areas 10178102 (to K. S.) from the Ministry of Education, Science, Culture, and Sports of Japan, as well as grants CA28734 and HD06763 from the National Institutes of Health (to M. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 81-78-441-7570; Fax: 81-78-441-7569; E-mail: k-sugar@kobepharma-u.ac.jp.

Published, JBC Papers in Press, May 30, 2001, DOI 10.1074/jbc.M102089200

2 Y. Tone, L. Pedersen, H. Kitagawa, J. Nishihara, J. Tamura, T. A. Darden, M. Negishi, and K. Sugahara, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: PG, proteoglycan; GAG, glycosaminoglycan; DS, dermatan sulfate; CS, chondroitin sulfate; HS, heparan sulfate; Hep, heparin; NMuMG, normal murine mammary gland; 2AB, 2-aminobenzamide; GlcN, D-glucosamine; HPLC, high performance liquid chromatography; Delta HexUA, 4-deoxy-alpha -L-threo-hex-4-enepyranosyluronic acid; Delta Di-0S, Delta HexUAalpha 1-3GalNAc; Delta Di-4S, Delta HexUAalpha 1- 3GalNAc(4-O-sulfate); Delta Di-6S, Delta HexUAalpha 1-3GalNAc(6-O-sulfate); Delta Di-diSD, Delta HexUA(2-O-sulfate)alpha 1-3GalNAc(6-O-sulfate); Delta Di-diSE, Delta HexUAalpha 1-3GalNAc(4,6-O-disulfate); Delta Di-triS, Delta HexUA(2-O-sulfate)alpha 1- 3GalNAc(4,6-O-disulfate); Delta DiHS-0S, Delta HexUAalpha 1-4GlcNAc; Delta DiHS-6S, Delta HexUAalpha 1-4GlcNAc(6-O-sulfate); Delta DiHS-NS, Delta HexUAalpha 1-4GlcN(2-N- sulfate); Delta DiHS-diS1, Delta HexUAalpha 1-4GlcN(2-N,6-O-disulfate); Delta DiHS-diS2, Delta HexUA(2-O-sulfate)alpha 1-4GlcN(2-N-sulfate); Delta DiHS-triS, Delta HexUA (2-O-sulfate)alpha 1-4GlcN(2-N,6-O-disulfate); Frs, fractions; mIU, milliinternational units.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Rodén, L. (1980) in The Biochemistry of Glycoproteins and Proteoglycans (Lennarz, W. J., ed) , pp. 267-371, Plenum Publishing Corp., New York
2. Lander, A. D. (1993) Curr. Opin. Neurobiol. 3, 716-723
3. Salmivirta, M., Lidholt, K., and Lindahl, U. (1996) FASEB J. 10, 1270-1279
4. Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., and Zako, M. (1999) Annu. Rev. Biochem. 68, 729-777
5. Oohira, A., Matsui, F., Tokita, Y., Yamauchi, S., and Aono, S. (2000) Arch. Biochem. Biophys. 374, 24-34
6. Lindahl, U., and Rodén, L. (1972) in Glycoproteins (Gottschalk, A., ed) , pp. 491-517, Elsevier Science Publishing Co., Inc., New York
7. Sugahara, K., Yamashina, I., De Waard, P., Van Halbeek, H., and Vliegenthart, J. F. G. (1988) J. Biol. Chem. 263, 10168-10174
8. Sugahara, K., and Kitagawa, H. (2000) Curr. Opin. Struct. Biol. 10, 518-527
9. Oegema, T. R., Jr., Kraft, E. L., Jourdian, G. W., and Van Valen, T. R. (1984) J. Biol. Chem. 259, 1720-1726
10. Fransson, L.-Å., Silverberg, I., and Carlstedt, I. (1985) J. Biol. Chem. 260, 14722-14726
11. Sugahara, K., Masuda, M., Harada, T., Yamashina, I., de Waard, P., and Vliegenthart, J. F. G. (1991) Eur. J. Biochem. 202, 805-811
12. Sugahara, K., Mizuno, N., Okumura, Y., and Kawasaki, T. (1992) Eur. J. Biochem. 204, 401-406
13. Sugahara, K., Ohi, Y., Harada, T., de Waard, P., and Vliegenthart, J. F. G. (1992) J. Biol. Chem. 267, 6027-6035
14. de Waard, P., Vliegenthart, J. F. G., Harada, T., and Sugahara, K. (1992) J. Biol. Chem. 267, 6036-6043
15. Sugahara, K., Ohkita, Y., Shibata, Y., Yoshida, K., and Ikegami, A. (1995) J. Biol. Chem. 270, 7204-7212
16. Yamada, S., Oyama, M., Kinugasa, H., Nakagawa, T., Kawasaki, T., Nagasawa, S., Khoo, K.-H., Morris, H. R., Dell, A., and Sugahara, K. (1995) Glycobiology 5, 335-341
17. Yamada, S., Oyama, M., Yuki, Y., Kato, K., and Sugahara, K. (1995) Eur. J. Biochem. 233, 687-693
18. De Beer, T., Inui, A., Tsuda, H., Sugahara, K., and Vliegenthart, J. F. G. (1996) Eur. J. Biochem. 240, 789-797
19. Lauder, R. M., Huckerby, T. N., and Nieduzynski, I. A. (2000) Biochem. J. 347, 339-348
20. Fransson, L. Å. (1987) Trends Biochem. Sci. 12, 406-411
21. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L., and Lose, E. J. (1992) Annu. Rev. Cell Biol. 8, 365-393
22. Perrimon, N., and Bernfield, M. (2000) Nature 404, 725-728
23. Tumova, S., Woods, A., and Couchman, J. R. (2000) Int. J. Biochem. Cell Biol. 32, 269-288
24. Sakaguchi, H., Watanabe, M., Ueoka, C., Sugiyama, E., Taketomi, T., Yamada, S., and Sugahara, K. (2001) J. Biochem. 129, 107-118
25. Tsukada, T., and Yoshino, M. (1987) Comp. Biochem. Physiol. 86B, 565-569
26. Yamada, S., Yoshida, K., Sugiura, M., and Sugahara, K. (1992) J. Biol. Chem. 112, 440-447
27. David, G., Van der Schueren, B., and Bernfield, M. (1981) J. Natl. Cancer Inst. 67, 719-728
28. Kato, M., Wang, H., Bernfield, M., Gallagher, J. T., and Turnbull, J. E. (1994) J. Biol. Chem. 269, 18881-18891
29. Jalkanen, M., Nguyen, H., Rapraeger, A., Kurn, N., and Bernfield, M. (1985) J. Cell Biol. 101, 976-984
30. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Anal. Biochem. 150, 76-85
31. Jalkanen, M., Rapraeger, A., and Bernfield, M. (1988) J. Cell Biol. 106, 953-962
32. Kato, M., Wang, H., Kainulainen, V., Fitzgerald, M. L., Ledbetter, S., Ornitz, D. M., and Bernfield, M. (1998) Nat. Med. 4, 691-697
33. Heinegård, D. (1972) Biochim. Biophys. Acta 285, 193-207
34. Kinoshita, A., and Sugahara, K. (1999) Anal. Biochem. 269, 367-378
35. Yamagata, T., Saito, H., Habuchi, O., and Suzuki, S. (1968) J. Biol. Chem. 243, 1523-1535
36. Yamada, S., Sakamoto, K., Tsuda, H., Yoshida, K., Sugahara, K., Khoo, K. H., Morris, H. R., and Dell, A. (1994) Glycobiology 4, 69-78
37. Sugahara, K., Shigeno, K., Masuda, M., Fujii, N., Kurosaka, A., and Takeda, K. (1994) Carbohydr. Res. 255, 145-163
38. Sugahara, K., Tsuda, H., Yoshida, K., Yamada, S., de Beer, T., and Vliegenthart, J. F. G. (1995) J. Biol. Chem. 270, 22914-22923
39. Yamada, S., and Sugahara, K. (1998) Trends Glycosci. Glycotechnol. 10, 95-123
40. Shibata, S., Midura, R. J., and Hascall, V. C. (1992) J. Biol. Chem. 267, 6548-6555
41. Moses, J., Oldberg, Å., Cheng, F., and Fransson, L. Å. (1997) Eur. J. Biochem. 248, 521-526
42. Rosenfeld, L., and Danishefsky, I. (1988) J. Biol. Chem. 263, 262-266
43. Cheng, F., Heinegård, D., Fransson, L.-Å., Bayliss, M., Bielicki, J., Hopwood, J., and Yoshida, K. (1996) J. Biol. Chem. 271, 28572-28580
44. Fritz, T. A., Gabb, M. M., Wei, G., and Esko, J. D. (1994) J. Biol. Chem. 269, 28809-28814
45. Kitagawa, H., Shimakawa, H., and Sugahara, K. (1999) J. Biol. Chem. 274, 13933-13937
46. Kim, B.-T., Kitagawa, H., Tamura, J., Saito, T., Kusche-Gullberg, M., Lindahl, U., and Sugahara, K. (2001) Proc. Natl. Acad. Sci. U. S. A.  98, 7176-7181
47. Rohrmann, K., Niemann, R., and Buddecke, E. (1985) Eur. J. Biochem. 148, 463-469
48. Nadanaka, S., Kitagawa, H., Goto, F., Tamura, J., Neumann, K. W., Ogawa, T., and Sugahara, K. (1999) Biochem. J. 340, 353-357
49. Zhang, L., and Esko, J. D. (1994) J. Biol. Chem. 269, 19295-19299
50. Zhang, L., David, G., and Esko, J. D. (1995) J. Biol. Chem. 270, 27127-27135
51. Dolan, M., Horchar, T., Rigatti, B., and Hassell, J. R. (1997) J. Biol. Chem. 272, 4316-4322
52. Chen, R. L., and Lander, A. D. (2001) J. Biol. Chem. 276, 7507-7517
53. Moses, J., Oldberg, Å., Eklund, E., and Fransson, L. Å. (1997) Eur. J. Biochem. 248, 767-774
54. Moses, J., Oldberg, Å., and Fransson, L. Å. (1999) Eur. J. Biochem. 260, 879-884
55. Pedersen, L. C., Tsuchida, K., Kitagawa, H., Sugahara, K., Darden, T. A., and Negishi, M. (2000) J. Biol. Chem. 275, 34580-34585
56. Kokenyesi, R., and Bernfield, M. (1994) J. Biol. Chem. 269, 12304-12309
57. Nadanaka, S., Kitagawa, K., and Sugahara, K. (1998) J. Biol. Chem. 273, 33728-33734
58. Vertel, B. M., Walters, L. M., Flay, N., Kearns, A. E., and Schwartz, N. B. (1993) J. Biol. Chem. 268, 11105-11112
59. Sugahara, K., and Yamada, S. (2000) Trends Glycosci. Glycotechnol. 12, 321-349
60. Nadanaka, S., Clement, A., Masayama, K., Faissner, A., and Sugahara, K. (1998) J. Biol. Chem. 273, 3296-3307
61. Clement, A. M., Sugahara, K., and Faissner, A. (1999) Neurosci. Lett. 269, 125-128
62. Maeda, N., Ichihara-Tanaka, K., Kimura, T., Kadomatsu, K., Muramatsu, T., and Noda, M. (1999) J. Biol. Chem. 274, 12474-12479
63. Ueoka, C., Kaneda, N., Okazaki, I., Nadanaka, S., Muramatsu, T., and Sugahara, K. (2000) J. Biol. Chem. 275, 37407-37413
64. Maeda, N., Nishiwaki, T., Shintani, T., Hamanaka, H., and Noda, M. (1996) J. Biol. Chem. 271, 21446-21452
65. Nakanishi, T., Kadomatsu, K., Okamoto, T., Ichihara-Tanaka, K., Kojima, T., Saito, H., Tomoda, Y., and Muramatsu, T. (1997) J. Biochem. 121, 197-205
66. Stoica, G. E., Kuo, A., Aigner, A., Sunitha, I., Souttou, B., Malerczyk, C., Caughey, D. J., Wen, D., Karavanov, A., Riegel, A. T., and Wellstein, A. (2001) J. Biol. Chem. 276, 16772-16779
67. Filla, M. S., Dam, P., and Rapraeger, A. C. (1998) J. Cell. Physiol. 174, 310-321
68. Fuki, I. V., Kuhn, K. M., Lomazov, I. R., Rothman, V. L., Tuszynski, G. P., Iozzo, R. V., Swenson, T. L., Fisher, E. A., and Williams, K. J. (1997) J. Clin. Invest. 100, 1611-1622
69. Koda, J. E., Rapraeger, A., and Bernfield, M. (1985) J. Biol. Chem. 260, 8157-8162
70. Edwards, I. J., Xu, H., Obunike, J. C., Goldberg, I. J., and Wagner, W. D. (1995) Arterioscler. Thromb. Vasc. Biol. 15, 400-409
71. Munakata, H., Takagaki, K., Majima, M., and Endo, M. (1999) Glycobiology 9, 1023-1027
72. Penc, S. F., Pomahac, B., Winkler, T., Dorschner, R. A., Eriksson, E., Herndon, M., and Gallo, R. L. (1998) J. Biol. Chem. 273, 28116-28121

Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
Y. Tone, L. C. Pedersen, T. Yamamoto, T. Izumikawa, H. Kitagawa, J. Nishihara, J.-i. Tamura, M. Negishi, and K. Sugahara
2-O-Phosphorylation of Xylose and 6-O-Sulfation of Galactose in the Protein Linkage Region of Glycosaminoglycans Influence the Glucuronyltransferase-I Activity Involved in the Linkage Region Synthesis
J. Biol. Chem., June 13, 2008; 283(24): 16801 - 16807.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
S. Yamada, H. Morimoto, T. Fujisawa, and K. Sugahara
Glycosaminoglycans in Hydra magnipapillata (Hydrozoa, Cnidaria): demonstration of chondroitin in the developing nematocyst, the sting organelle, and structural characterization of glycosaminoglycans
Glycobiology, August 1, 2007; 17(8): 886 - 894.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Purushothaman, J. Fukuda, S. Mizumoto, G. B. ten Dam, T. H. van Kuppevelt, H. Kitagawa, T. Mikami, and K. Sugahara
Functions of Chondroitin Sulfate/Dermatan Sulfate Chains in Brain Development: CRITICAL ROLES OF E AND iE DISACCHARIDE UNITS RECOGNIZED BY A SINGLE CHAIN ANTIBODY GD3G7
J. Biol. Chem., July 6, 2007; 282(27): 19442 - 19452.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
H. Nakagawa, Y. Hama, T. Sumi, S.-C. Li, K. Maskos, K. Kalayanamitra, S. Mizumoto, K. Sugahara, and Y.-T. Li
Occurrence of a nonsulfated chondroitin proteoglycan in the dried saliva of Collocalia swiftlets (edible bird's-nest)
Glycobiology, February 1, 2007; 17(2): 157 - 164.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Bergefall, E. Trybala, M. Johansson, T. Uyama, S. Naito, S. Yamada, H. Kitagawa, K. Sugahara, and T. Bergstrom
Chondroitin Sulfate Characterized by the E-disaccharide Unit Is a Potent Inhibitor of Herpes Simplex Virus Infectivity and Provides the Virus Binding Sites on gro2C Cells
J. Biol. Chem., September 16, 2005; 280(37): 32193 - 32199.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Tveit, G. Dick, V. Skibeli, and K. Prydz
A Proteoglycan Undergoes Different Modifications en Route to the Apical and Basolateral Surfaces of Madin-Darby Canine Kidney Cells
J. Biol. Chem., August 19, 2005; 280(33): 29596 - 29603.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Gulberti, V. Lattard, M. Fondeur, J.-C. Jacquinet, G. Mulliert, P. Netter, J. Magdalou, M. Ouzzine, and S. Fournel-Gigleux
Phosphorylation and Sulfation of Oligosaccharide Substrates Critically Influence the Activity of Human {beta}1,4-Galactosyltransferase 7 (GalT-I) and {beta}1,3-Glucuronosyltransferase I (GlcAT-I) Involved in the Biosynthesis of the Glycosaminoglycan-Protein Linkage Region of Proteoglycans
J. Biol. Chem., January 14, 2005; 280(2): 1417 - 1425.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. S. Deepa, S. Yamada, M. Zako, O. Goldberger, and K. Sugahara
Chondroitin Sulfate Chains on Syndecan-1 and Syndecan-4 from Normal Murine Mammary Gland Epithelial Cells Are Structurally and Functionally Distinct and Cooperate with Heparan Sulfate Chains to Bind Growth Factors: A NOVEL FUNCTION TO CONTROL BINDING OF MIDKINE, PLEIOTROPHIN, AND BASIC FIBROBLAST GROWTH FACTOR
J. Biol. Chem., September 3, 2004; 279(36): 37368 - 37376.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Gao, A. Plaas, V. P. Thompson, S. Jin, F. Zuo, and J. D. Sandy
ADAMTS4 (Aggrecanase-1) Activation on the Cell Surface Involves C-terminal Cleavage by Glycosylphosphatidyl Inositol-anchored Membrane Type 4-Matrix Metalloproteinase and Binding of the Activated Proteinase to Chondroitin Sulfate and Heparan Sulfate on Syndecan-1
J. Biol. Chem., March 12, 2004; 279(11): 10042 - 10051.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. M. Shannon, K. McCormick-Shannon, M. S. Burhans, X. Shangguan, K. Srivastava, and B. A. Hyatt
Chondroitin sulfate proteoglycans are required for lung growth and morphogenesis in vitro
Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1323 - L1336.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Jonsson, E. Eklund, L.-A. Fransson, and A. Oldberg
Initiation of the Decorin Glycosaminoglycan Chain in the Endoplasmic Reticulum-Golgi Intermediate Compartment
J. Biol. Chem., June 6, 2003; 278(24): 21415 - 21420.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Zako, J. Dong, O. Goldberger, M. Bernfield, J. T. Gallagher, and J. A. Deakin
Syndecan-1 and -4 Synthesized Simultaneously by Mouse Mammary Gland Epithelial Cells Bear Heparan Sulfate Chains That Are Apparently Structurally Indistinguishable
J. Biol. Chem., April 4, 2003; 278(15): 13561 - 13569.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. GOTTE
Syndecans in inflammation
FASEB J, April 1, 2003; 17(6): 575 - 591.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Uyama, H. Kitagawa, J. Tanaka, J.-i. Tamura, T. Ogawa, and K. Sugahara
Molecular Cloning and Expression of a Second Chondroitin N-Acetylgalactosaminyltransferase Involved in the Initiation and Elongation of Chondroitin/Dermatan Sulfate
J. Biol. Chem., January 24, 2003; 278(5): 3072 - 3078.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. S. Deepa, Y. Umehara, S. Higashiyama, N. Itoh, and K. Sugahara
Specific Molecular Interactions of Oversulfated Chondroitin Sulfate E with Various Heparin-binding Growth Factors. IMPLICATIONS AS A PHYSIOLOGICAL BINDING PARTNER IN THE BRAIN AND OTHER TISSUES
J. Biol. Chem., November 8, 2002; 277(46): 43707 - 43716.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. G. Seidler, E. Breuer, K. J. Grande-Allen, V. C. Hascall, and H. Kresse
Core Protein Dependence of Epimerization of Glucuronosyl Residues in Galactosaminoglycans
J. Biol. Chem., October 25, 2002; 277(44): 42409 - 42416.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Yamada, Y. Okada, M. Ueno, S. Iwata, S. S. Deepa, S. Nishimura, M. Fujita, I. Van Die, Y. Hirabayashi, and K. Sugahara
Determination of the Glycosaminoglycan-Protein Linkage Region Oligosaccharide Structures of Proteoglycans from Drosophila melanogaster and Caenorhabditis elegans
J. Biol. Chem., August 23, 2002; 277(35): 31877 - 31886.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Farzan, G. J. Babcock, N. Vasilieva, P. L. Wright, E. Kiprilov, T. Mirzabekov, and H. Choe
The Role of Post-translational Modifications of the CXCR4 Amino Terminus in Stromal-derived Factor 1alpha Association and HIV-1 Entry
J. Biol. Chem., August 9, 2002; 277(33): 29484 - 29489.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Tsuchida, J. Shioi, S. Yamada, G. Boghosian, A. Wu, H. Cai, K. Sugahara, and N. K. Robakis
Appican, the Proteoglycan Form of the Amyloid Precursor Protein, Contains Chondroitin Sulfate E in the Repeating Disaccharide Region and 4-O-Sulfated Galactose in the Linkage Region
J. Biol. Chem., September 28, 2001; 276(40): 37155 - 37160.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/31/29134    most recent
M102089200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueno, M.
Right arrow Articles by Sugahara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueno, M.
Right arrow Articles by Sugahara, K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement